Skip to content

Xencor XNCR Stock-Based Comp

Stock-Based Comp at other companies

Amgen logo
AmgenAMGN
$75M-11.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$257.4M+0.7%
Janux Therapeutics logo
Janux TherapeuticsJANX
$9.27M-13.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$12.01M-18.8%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$14.22M+55.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$16.89M+38.8%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's stock-based comp?
Xencor (XNCR) reported stock-based comp of $9.56M in Q1 2026.
How has Xencor's stock-based comp changed year-over-year?
Xencor's stock-based comp decreased by 21.7% year-over-year, from $12.21M to $9.56M.
What is the long-term trend for Xencor's stock-based comp?
Over 4 years (2021 to 2025), Xencor's stock-based comp has grown at a 4.0% compound annual growth rate (CAGR), from $36.98M to $43.23M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.